The Journal of the Korea Contents Association (한국콘텐츠학회논문지)

The Korea Contents Association (한국콘텐츠학회)
권호 표지
DOI QR코드

DOI QR Code

Comparison of ASCUS and Human Papilloma Virus

미확정 편평상피세포와 인체 유두종바이러스와의 비교

  • 박미순 (한서대학교 보건의료학과) ;
  • 장병수 (한서대학교 피부미용학과)
  • Received : 2013.07.15
  • Accepted : 2013.07.31
  • Published : 2013.08.31
Download PDF
⟨ Previous Next ⟩

Abstract

Among 179 specimen diagnosed with ASCUS but did not go through biopsy or other tests, 26 cases (14.52%) showed positivity in HPV Hybrid Capture II Test. There were 25 cases of HPV high risk factor(+), marking 13.96%, and 3 cases of low risk factor(+) at 1.67%. According to cytology manifestation, patients with over LSIL can increase their complete recovery rate with continuous tests, but most patients diagnosed ASCUS do not go through any tests at all. It is considered that in order to prevent and start early treatment on cervical cancer, the HPV Hybrid Capture II Test must be enforced to patients diagnosed with ASCUS. Negative patients should go through routine screening, and positive patients should receive treatment after colposcopy.

세포선별검사에서 ASCUS로 진단된 검체 중 F-UP이 진행되지 않은 검체 179건을 대상으로 HPV high risk factor, low risk factor를 확인하기 위해서 Hybrid Capture II Test를 하였다. 시험 결과 high risk factor 양성 및 low risk factor 양성은 전체 179 cases 중 26 cases로 나타났으며, 전체 검체 중 약 15%에 해당되었다. 또한 전체 15%의 양성검체 중 high risk factor 양성은 96%에 해당되는 것을 확인하였다. 결론적으로 효과적인 검진 체계를 갖춘 나라에서도 자궁경부암의 예방이 완전히 해결되지 않고 있는 문제점이 있는 여건을 고려해 볼 때 추적 관찰이 용이하지 않은 경우를 대비해 자궁경부암으로 진행될 수 있는 precancerous lesion의 원인 인자인 HPV 존재 유무를 세포선별검사와 HPV Hybrid Capture II Test를 동시에 시행하는 것이 효과적이라고 사료된다.

Keywords

References

  1. C. S. Herrington, M. F. Evans, W. Gray, and J. O. D. McGee, "Morphological correlation of human papilloma virus infection of matched cervical smears and bioscopes from patients with persistant mild cervical cytological abnorminalities," Human Pathol, Vol.26, pp.951-955, 1995. https://doi.org/10.1016/0046-8177(95)90083-7
  2. A. Schneider, "Cervical and vaginal HPV infections," Clin Dermatol, Vol.15, pp.389-398, 1997. https://doi.org/10.1016/S0738-081X(96)00158-7
  3. R. Kurman, and D. Solomon, "The bethesda system for reporting cervical/vaginal cytologic diagnosis: definitions, criteria and explanatory notes for terminology and specimen adequacy," New York, Springer Verlag, pp.148-156, 1994.
  4. L. C. R. Tewari, and C. A. Chaudhary, "Atypical squamous cells of undetermined significance, a follow up study," MJAFI, Vol.66, pp.225-227, 2010.
  5. F. X. Bosch, M. M. Manos, and N. Munoz, "Prevalence of human papilloma virus in cervical cancer: a worldwide perspective," J Natl Cancer Inst, Vol.87, pp.796-802, 1995. https://doi.org/10.1093/jnci/87.11.796
  6. M. del Pino, L. Rodriguez-Carunchio, I. Alonso, A. Torne, A. Rodriguez, P. Fuste, P. Castillo, N. Nonell, N. Abu-Lhiga, and J. Ordi, "Clinical, colposcopic and pathological charateristics of cervical and vaginal high-grade negative for HPV by Hybrid Capture 2," Gynecol Oncol, Vol.122, pp.515-520, 2011. https://doi.org/10.1016/j.ygyno.2011.05.012
  7. M. L. Williams, D. L. Rimm, M. A. Pedigo, and W. J. Frable, "Atypical squamous cells of undetermined significance: correlative histologic and follow-up studies from a academic medical center," Diagn Cytopathol, Vol.16, pp.1-7, 1997. https://doi.org/10.1002/(SICI)1097-0339(199701)16:1<1::AID-DC2>3.0.CO;2-M
  8. K. W. Alanen, L. M. Elit, P. A. Molinaro, and C. M. McLachlin, "Accesment of cytologic follow-up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesion," Cancer, Vol.84, pp.5-10, 1988.
  9. K. A. Dvorak, M. Finnemore, and J. A. Mksem, "Histology correlation with atypical squamous cells of undetermined significance(ASCUS) or low grade squamous intraepithelial lesion(LSIL) cytology diagnosis: an argument to ensure ASCUS follow-up that is as aggressive as that for LSIL," Diagn Cytopathol, Vol.21, pp.292-295, 1999. https://doi.org/10.1002/(SICI)1097-0339(199910)21:4<292::AID-DC13>3.0.CO;2-N
  10. I. Nindil, A. Lorincz, I. Mielzynska, U. Petry, S. Baur, R. Kirchmayr, W. Michels, and A. Schneider, "Human papilloma virus detection in cervical intraneoplasia by the second-generation hybrid capture microplate test, comparing two different cervical specimen collection methods," Clin Diagn Virol, Vol.10, pp.49-56, 1998. https://doi.org/10.1016/S0928-0197(98)00015-4
  11. T. C. Wright, X. W. Sun, and J. Koulos, "Comparision of management algorythms for the evaluation of women with low-grade cytologic abnormalities," Obstet Gynecol, Vol.85, pp.202-210, 1995. https://doi.org/10.1016/0029-7844(94)00373-L
  12. N. Munoz, F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. Shah, and P. J. Snijders, "Epidermiologic classification of human papillomavirus types associated with cervical cancer," N Engl J Med, Vol.348, pp.518-527, 2003. https://doi.org/10.1056/NEJMoa021641
  13. C. Perrons, R. Jelley, B. Klete, W. Quint, and N. Brink, "Detection of persistent high risk human papilloma virus injections with hybrid capture II and SPF10/LiPA, J Clin Virol, Vol.32, pp.278-285, 2005. https://doi.org/10.1016/j.jcv.2004.08.009
  14. World Health Organization, "WHO position on HPV vaccines," Vaccine, Vol.27, pp.7236-7237, 2009. https://doi.org/10.1016/j.vaccine.2009.05.019